{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 3, "transaction_limit": 160, "filters": {"q": "", "ticker": "AXSM", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 3, "acquisition_count": 1, "disposal_count": 2, "acquisition_value": 245846.7, "acquisition_value_label": "$245.8K", "disposal_value": 11932256.5, "disposal_value_label": "$11.9M", "net_value": -11686409.8, "net_value_label": "$-11.7M", "flow_tone": "negative", "largest_value_label": "$11.9M", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 3, "value": "12178103.2000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$12.2M"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 100.0}], "side_mix": {"acquisitions": 1, "disposals": 2, "acquisition_share": 33.3, "disposal_share": 66.7}}, "company_flows": [{"symbol": "AXSM", "name": "Axsome Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "acquisitions": 1, "disposals": 2, "acquired_value": 245846.7, "acquired_value_label": "$245.8K", "disposed_value": 11932256.5, "disposed_value_label": "$11.9M", "net_value": -11686409.8, "net_value_label": "$-11.7M", "acquisition_share": 33.3, "disposal_share": 66.7, "detail_url": "https://sharemaestro.com/insider-activity/company/axsm/", "research_links": {"chart": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/", "report": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/report/", "factor": "/factors/ticker/86a31fb0-b9c6-4524-b036-38f4458324ed/"}}], "company_overview": [{"symbol": "AXSM", "name": "Axsome Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "filings": 3, "acquisitions": 1, "disposals": 2, "acquired_value": 245846.7, "acquired_value_label": "$245.8K", "disposed_value": 11932256.5, "disposed_value_label": "$11.9M", "net_value": -11686409.8, "net_value_label": "$-11.7M", "acquisition_share": 33.3, "disposal_share": 66.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/axsm/", "research_links": {"chart": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/", "report": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/report/", "factor": "/factors/ticker/86a31fb0-b9c6-4524-b036-38f4458324ed/"}}], "transactions": [{"symbol": "AXSM", "name": "Axsome Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "TABUTEAU, HERRIOT", "executive_title": "Director, Chief Executive Officer, 10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 49666.0, "share_price": 240.25, "transaction_value": 11932256.5, "fetched_at": "2026-07-21T22:00:33.975402+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/axsm/", "research_links": {"chart": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/", "report": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/report/", "factor": "/factors/ticker/86a31fb0-b9c6-4524-b036-38f4458324ed/"}}, {"symbol": "AXSM", "name": "Axsome Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "TABUTEAU, HERRIOT", "executive_title": "Director, Chief Executive Officer, 10% Owner", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 49666.0, "share_price": 4.95, "transaction_value": 245846.7, "fetched_at": "2026-07-21T22:00:33.974051+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/axsm/", "research_links": {"chart": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/", "report": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/report/", "factor": "/factors/ticker/86a31fb0-b9c6-4524-b036-38f4458324ed/"}}, {"symbol": "AXSM", "name": "Axsome Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "TABUTEAU, HERRIOT", "executive_title": "Director, Chief Executive Officer, 10% Owner", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 49666.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:00:33.971855+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/axsm/", "research_links": {"chart": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/", "report": "/terminal/86a31fb0-b9c6-4524-b036-38f4458324ed/report/", "factor": "/factors/ticker/86a31fb0-b9c6-4524-b036-38f4458324ed/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}